These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 20688577)

  • 1. Definitive 125I prostate brachytherapy implant for low-risk prostate cancer in a patient with an ileal pouch-anal anastomosis: a case report.
    Miles EF; Nelson JW
    Brachytherapy; 2011; 10(2):117-20. PubMed ID: 20688577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate brachytherapy after ileal pouch-anal anastomosis reconstruction.
    Williamson R; Smaldone MC; Gibbons EP; Smith RP; Beriwal S; Benoit RM
    Urology; 2009 Feb; 73(2):369-73. PubMed ID: 18708241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors in the outcome of 125I brachytherapy as monotherapy for prostate cancer.
    Hinnen KA; van Vulpen M
    Expert Rev Anticancer Ther; 2011 Jan; 11(1):115-23. PubMed ID: 21166516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of perineural invasion on biochemical outcome after permanent prostate iodine-125 brachytherapy.
    Piña AG; Crook JM; Kwan P; Borg J; Ma C
    Brachytherapy; 2010; 9(3):213-8. PubMed ID: 20022565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experience with 125I brachytherapy as a radical treatment for prostate cancer at the Russian X-ray Radiology Research Center].
    Kaprin AD; Milenin KN; Ivanov SA; Tsybul'skiĭ AD; Gerasimov AA
    Vestn Rentgenol Radiol; 2011; (1):26-8. PubMed ID: 21598469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate-specific antigen relapse-free survival and side-effects in 734 patients with up to 10 years of follow-up with localized prostate cancer treated by permanent iodine implants.
    Prada PJ; Juan G; González-Suárez H; Fernández J; Jimenez I; Amón J; Cepeda M
    BJU Int; 2010 Jul; 106(1):32-6. PubMed ID: 20067460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Brachytherapy of 125I implantation for localized prostate cancer (report of 41 cases)].
    Bai Q; Wang Y; Kaye KW
    Zhonghua Nan Ke Xue; 2004 May; 10(5):371-3. PubMed ID: 15190833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation safety aspects of brachytherapy for prostate cancer using permanently implanted sources. A report of ICRP Publication 98.
    International Commission on Radiological Protection
    Ann ICRP; 2005; 35(3):iii-vi, 3-50. PubMed ID: 16330284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective assessment of patient-reported long-term urinary morbidity and associated quality of life changes after 125I prostate brachytherapy.
    Stone NN; Stock RG
    Brachytherapy; 2003; 2(1):32-9. PubMed ID: 15062161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Median 5 year follow-up of 125iodine brachytherapy as monotherapy in men agedGómez-Iturriaga Piña A; Crook J; Borg J; Lockwood G; Fleshner N
    Urology; 2010 Jun; 75(6):1412-6. PubMed ID: 20035986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential comparison of seed loss and prostate dosimetry of stranded seeds with loose seeds in 125I permanent implant for low-risk prostate cancer.
    Saibishkumar EP; Borg J; Yeung I; Cummins-Holder C; Landon A; Crook J
    Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):61-8. PubMed ID: 18823713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technical acquisition and dosimetric assessment of iodine-125 permanent brachytherapy in localized prostate cancer: our first series of 100 patients.
    Tanaka N; Asakawa I; Kondo H; Tanaka M; Fujimoto K; Hasegawa M; Konishi N; Hirao Y
    Int J Urol; 2009 Jan; 16(1):70-4. PubMed ID: 19120529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate-specific antigen bounce after permanent iodine-125 prostate brachytherapy--an Australian analysis.
    Zwahlen DR; Smith R; Andrianopoulos N; Matheson B; Royce P; Millar JL
    Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):179-87. PubMed ID: 20378267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iodine-125 brachytherapy for prostate cancer: first published Australian experience.
    Joseph DJ; Woo TC; Haworth A
    Australas Radiol; 2004 Jun; 48(2):181-7. PubMed ID: 15230752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Iodine-125 implantation in localized prostate cancer].
    Battermann JJ
    Ned Tijdschr Geneeskd; 1998 May; 142(21):1228-9. PubMed ID: 9627460
    [No Abstract]   [Full Text] [Related]  

  • 16. [Physical basics and clinical realization of interstitial brachytherapy of the prostate with iodine 125].
    Kaulich TW; Lamprecht U; Paulsen F; Kahmann F; Maurer U; Henkel TO; Loeser W; Bichler KH; Nüsslin F; Bamberg M
    Strahlenther Onkol; 2002 Oct; 178(10):548-55. PubMed ID: 12386786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic intraoperative dosimetry for prostate brachytherapy using a nonisocentric C-arm.
    Song DY; Jain AK; Zhang Z; Deguet A; Le Y; Armour E; Burdette EC; Fichtinger G
    Brachytherapy; 2011; 10(2):98-106. PubMed ID: 20692212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional outcome and quality of life after repeat ileal pouch-anal anastomosis for complications of ileoanal surgery.
    Baixauli J; Delaney CP; Wu JS; Remzi FH; Lavery IC; Fazio VW
    Dis Colon Rectum; 2004 Jan; 47(1):2-11. PubMed ID: 14719144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Permanent 125I-seed brachytherapy or radical prostatectomy: a prospective comparison considering oncological and quality of life results.
    Borchers H; Kirschner-Hermanns R; Brehmer B; Tietze L; Reineke T; Pinkawa M; Eble MJ; Jakse G
    BJU Int; 2004 Oct; 94(6):805-11. PubMed ID: 15476513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quadrant dosimetry as a predictor of biochemical relapse in 125I prostate brachytherapy.
    Spadinger I; Morris WJ; Keyes M; Liu M; Shaffer R; Thompson A; Chng N; Woods R
    Brachytherapy; 2011; 10(2):87-97. PubMed ID: 20691643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.